DPHCC simultaneously expressed the cholangiocyte marker CK19 (red) and the hepatocyte marker Hep par1 (green), and both markers co-expressed more than 15% of tumor cells (green and red overlap more than 15%). Here, KRT19 is linked to neoplasm.